Concepedia

Kostas Gavardinas

KG

Statistics

Publications

3

Citations

128

H-Index

3

Active since

2014

Affiliations

Eli Lilly (United States)(Current)

Kostas Gavardinas is an author at Eli Lilly (United States) specializing in pharmacology, endocrinology, and endocrine pharmacology.

Publications per year

2014–2018

3

Publications

3

Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic Aneurysm

Prabhakar K. Jadhav, Matthew A. Schiffler, Kostas Gavardinas et al. · ACS Medicinal Chemistry Letters · 2014 · 67 citations · Full text

, , +13

2-Chloro-4-[[(1<i>R</i>,2<i>R</i>)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy

Ashraf Saeed, Grant M. Vaught, Kostas Gavardinas et al. · Journal of Medicinal Chemistry · 2015 · 39 citations · Full text

, , +15

Development of a selective androgen receptor modulator for transdermal use in hypogonadal patients

Venkatesh Krishnan, Nita Patel, James G. MacKrell et al. · Andrology · 2018 · 22 citations · Full text

, , +17

1–3 of 3